SOLICITATION NOTICE
B -- Exosome mi RNA Profiling, Sequencing, and Analysis Service Contract
- Notice Date
- 8/5/2022 4:38:42 PM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
- ZIP Code
- 20705
- Solicitation Number
- FDA-22-1255259
- Response Due
- 8/17/2022 12:00:00 PM
- Archive Date
- 09/01/2022
- Point of Contact
- Kimberly DeLong
- E-Mail Address
-
kimberly.delong@fda.hhs.gov
(kimberly.delong@fda.hhs.gov)
- Small Business Set-Aside
- SBA Total Small Business Set-Aside (FAR 19.5)
- Description
- **Amendment 01- we received questions and are working on providing responses in the next few days.� At this point, we are extending the due date to 8/17. The project requires identifying novel biomarkers by characterizing exosome associated small RNAs from tissue culture media, serum, or other patient biofluids. They should be able to do RNA quality, purity, RNA integrity, and concentration check. Sequencing library preparation and data analysis. Number of Samples: 75 samples The exosome miRNA biomarker discovery project will help understand pathogenesis and disease progression along with diagnostic markers for different strains of HIV. The newly identified miRNA will be further validated inhibitory studies. These observations will help to identify strain-specific miRNA further.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/bc18c4de5a5846dcbe44a0378dcf9242/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06415925-F 20220807/220805230116 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |